99 related articles for article (PubMed ID: 21072068)
41. [Construction of a RU486 inducible recombinant adenoviral vector carrying murine interleukin-12 gene and experimental treatment of colonic carcinoma].
Chen J; Liu XS; Wang F; Xue XC; Fang GE; Su CQ; Qian QJ
Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1372-6. PubMed ID: 19671324
[TBL] [Abstract][Full Text] [Related]
42. [The feasibility and mechanism of recombinant adenovirus Ad - p 14 ARF in gene therapy of liver cancer].
Song HF; Qian HL; Zhang XY; Liang X; Fu M; Lin C
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):641-5. PubMed ID: 17274365
[TBL] [Abstract][Full Text] [Related]
43. Anticancer activity of oncolytic adenoviruses carrying p53 is augmented by 11R in gallbladder cancer cell lines in vitro and in vivo.
Wang J; Yu Y; Yan Z; Hu Z; Li L; Li J; Jiang X; Qian Q
Oncol Rep; 2013 Aug; 30(2):833-41. PubMed ID: 23727990
[TBL] [Abstract][Full Text] [Related]
44. Targeting gene-virus-mediated manganese superoxide dismutase effectively suppresses tumor growth in hepatocellular carcinoma in vitro and in vivo.
Huang F; Ma B; Wang Y; Xiao R; Kong Y; Zhou X; Xia D
Cancer Biother Radiopharm; 2014 Dec; 29(10):403-11. PubMed ID: 25414976
[TBL] [Abstract][Full Text] [Related]
45. In vivo bioluminescent imaging of α-fetoprotein-producing hepatocellular carcinoma in the diethylnitrosamine-treated mouse using recombinant adenoviral vector.
Kim KI; Park JH; Lee YJ; Lee TS; Park JJ; Song I; Nahm SS; Cheon GJ; Lim SM; Chung JK; Kang JH
J Gene Med; 2012 Aug; 14(8):513-20. PubMed ID: 22761128
[TBL] [Abstract][Full Text] [Related]
46. Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy.
Kang JH; Chung JK; Lee YJ; Shin JH; Jeong JM; Lee DS; Lee MC
J Nucl Med; 2004 Sep; 45(9):1571-6. PubMed ID: 15347726
[TBL] [Abstract][Full Text] [Related]
47. [131I]meta-iodobenzylguanidine and topotecan combination treatment of tumors expressing the noradrenaline transporter.
McCluskey AG; Boyd M; Ross SC; Cosimo E; Clark AM; Angerson WJ; Gaze MN; Mairs RJ
Clin Cancer Res; 2005 Nov; 11(21):7929-37. PubMed ID: 16278418
[TBL] [Abstract][Full Text] [Related]
48. Efficient melanoma cell killing and reduced melanoma growth in mice by a selective replicating adenovirus armed with tumor necrosis factor-related apoptosis-inducing ligand.
Fecker LF; Rückert S; Kurbanov BM; Schmude M; Stockfleth E; Fechner H; Eberle J
Hum Gene Ther; 2011 Apr; 22(4):405-17. PubMed ID: 20977303
[TBL] [Abstract][Full Text] [Related]
49. [Construction of recombinant adenovirus containing mIkappaBalpha gene by homogenous recombination in E.coli. and its expression in Hep G2 cells].
Jin WD; Chen LH; Mu F
Di Yi Jun Yi Da Xue Xue Bao; 2005 Mar; 25(3):308-12. PubMed ID: 15772000
[TBL] [Abstract][Full Text] [Related]
50. [Recombinant adenovirus-mediated overexpression of TIMP-1 effectively suppresses hepatocellular carcinoma cell line HepG2 in vitro and in vivo].
Xia D; Xu L; Fu H; Qi XL; Quan Y; Yan LN
Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):813-7. PubMed ID: 18396636
[TBL] [Abstract][Full Text] [Related]
51. Adenovirus-mediated hypoxia-targeted gene therapy using HSV thymidine kinase and bacterial nitroreductase prodrug-activating genes in vitro and in vivo.
Harvey TJ; Hennig IM; Shnyder SD; Cooper PA; Ingram N; Hall GD; Selby PJ; Chester JD
Cancer Gene Ther; 2011 Nov; 18(11):773-84. PubMed ID: 21836632
[TBL] [Abstract][Full Text] [Related]
52. Adenovirus-mediated tBid overexpression results in therapeutic effects on p53-resistant hepatocellular carcinoma.
Miao J; Chen GG; Chun SY; Yun JP; Chak EC; Ho RL; Lai PB
Int J Cancer; 2006 Oct; 119(8):1985-93. PubMed ID: 16708390
[TBL] [Abstract][Full Text] [Related]
53. ICAM-2 gene therapy for peritoneal dissemination of scirrhous gastric carcinoma.
Tanaka H; Yashiro M; Sunami T; Sakate Y; Kosaka K; Hirakawa K
Clin Cancer Res; 2004 Jul; 10(14):4885-92. PubMed ID: 15269165
[TBL] [Abstract][Full Text] [Related]
54. Gene manipulation to enhance MIBG-targeted radionuclide therapy.
Mairs RJ; Fullerton NE; Cosimo E; Boyd M
Nucl Med Biol; 2005 Oct; 32(7):749-53. PubMed ID: 16243651
[TBL] [Abstract][Full Text] [Related]
55. Dual induction of PKR with E2F-1 and IFN-alpha to enhance gene therapy against hepatocellular carcinoma.
Roh V; Laemmle A; Von Holzen U; Stroka D; Dufour JF; Hunt KK; Candinas D; Vorburger SA
Cancer Gene Ther; 2008 Oct; 15(10):636-44. PubMed ID: 18535617
[TBL] [Abstract][Full Text] [Related]
56. Complete eradication of hepatomas using an oncolytic adenovirus containing AFP promoter controlling E1A and an E1B deletion to drive IL-24 expression.
Zhang KJ; Zhang J; Wu YM; Qian J; Liu XJ; Yan LC; Zhou XM; Xiao RJ; Wang YG; Cao X; Wei N; Liu XR; Tang B; Jiao XY; Chen K; Liu XY
Cancer Gene Ther; 2012 Sep; 19(9):619-29. PubMed ID: 22790965
[TBL] [Abstract][Full Text] [Related]
57. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
58. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM
Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705
[TBL] [Abstract][Full Text] [Related]
59. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
60. Imaging of radioiodine-labeled KH901, a tumor-specific oncolytic recombinant adenovirus, in nude mice with human hepatocellular carcinoma.
Mi YX; Li YC; Long YH
Nucl Med Commun; 2010 May; 31(5):405-10. PubMed ID: 20147862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
